李寧、安踏、海底撈等消費白馬股集體下跌,年末獲利資金落袋為安?
格隆匯12月10日丨港股市場消費白馬股近日持續下跌,今日跌勢繼續。其中,李寧、安踏、波司登、海底撈、頤海國際等跌幅居前。

截至目前,李寧年內累漲185%,估值39倍;安踏年內累漲90%,估值36倍;波司登年內累漲127%,估值30倍;海底撈累漲89%,估值79倍;頤海國際累漲138%,估值69倍。
有分析人士稱,這些股票過往漲幅過大、估值過高,存在調整壓力,年終將至,獲利盤資金存在落袋為安的需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.